Article
Surgery
Neal S. Panse, Vishnu Prasath, Patrick L. Quinn, Ravi J. Chokshi
Summary: This study compared the cost-effectiveness of robotic-assisted and laparoscopic surgery for paraesophageal hernia repair, and found that laparoscopic surgery is more cost-effective.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2023)
Review
Oncology
Hanlin Fu, Jiahui Zhang, Shiyi Zhao, Nannan He
Summary: Robotic-assisted laparoscopy (RALS) is safe and provides long-term oncological outcomes equivalent to conventional laparoscopy (CLS) and superior to laparotomy (LT) for endometrial cancer.
GYNECOLOGIC ONCOLOGY
(2023)
Article
Cardiac & Cardiovascular Systems
Brendan T. Heiden, Joshua D. Mitchell, Eric Rome, Varun Puri, Bryan F. Meyers, Su-Hsin Chang, Benjamin D. Kozower
Summary: Compared with VATS, RAL is not cost-effective for lung cancer lobectomy at lower willingness-to-pay thresholds. However, several factors including lower robotic instrument costs, shorter operating room times, lower conversion rates, shorter lengths of stay, higher hospital volumes, and improved quality of life may drive RAL to emerge as the more cost-effective approach for minimally invasive lung cancer resection.
ANNALS OF THORACIC SURGERY
(2022)
Article
Oncology
Oksana Movchan, Valentin Svintsitskyi
Summary: The feasibility of pelvic and para-aortic lymph node dissection in patients with endometrial cancer is evaluated in this study, based on disease stage, postoperative complications, and patient survival. The duration of the operation and the number of lymph nodes removed are found to be closely related to the volume of surgical intervention.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2023)
Article
Surgery
Vanessa El-Achi, Jennifer Weishaupt, Jonathan Carter, Sam Saidi
Summary: Surgery is the main treatment for endometrial cancer and complex atypical endometrial hyperplasia. Robotic-assisted hysterectomy is increasingly used in morbidly obese patients, especially in women with a BMI over 50 kg/m(2).
JOURNAL OF ROBOTIC SURGERY
(2021)
Article
Oncology
Nnamdi I. Gwacham, Karolina A. Kilowski, Fernando O. Recio, Ahmad Awada, Theresa M. Kuhn, Jianbin Zhu, Ameya Patel, Sarfraz Ahmad, Nathalie D. McKenzie, James E. Kendrick, Robert W. Holloway
Summary: The study aimed to determine the prevalence of peritoneal cytologic contamination following robotic hysterectomy for endometrial cancer. The results showed that 13.1% of cases had pelvic contamination. Pelvic contamination was associated with factors such as myometrial invasion, tumor size, lymphovascular space invasion, and lymph node metastasis. Rating: 8 out of 10.
GYNECOLOGIC ONCOLOGY
(2023)
Article
Oncology
C. Uwins, H. Patel, G. Prakash Bhandoria, S. Butler-Manuel, A. Tailor, P. Ellis, J. Chatterjee
Summary: Minimally invasive surgery has multiple benefits for the treatment of endometrial and cervix cancer, but oncological efficacy and safety should be rigorously established when adopting new techniques, rather than assumed based on first principles.
Article
Oncology
Emanuele Perrone, Ilaria Capasso, Tina Pasciuto, Alessandro Gioe, Salvatore Gueli Alletti, Stefano Restaino, Giovanni Scambia, Francesco Fanfani
Summary: The study found that robotic-assisted surgery (RS) and laparoscopy (LPS) have similar efficacy and safety for endometrial cancer staging. The different surgical approaches did not significantly influence disease-free survival (DFS) or overall survival (OS). Age was found to be a significant factor for survival in high-risk endometrial cancer patients, independent of the minimally invasive approach.
JOURNAL OF GYNECOLOGIC ONCOLOGY
(2021)
Article
Multidisciplinary Sciences
Felix Machleid, Jenessa Ho-Wrigley, Ameera Chowdhury, Anita Paliah, Ho Lam Poon, Elena Pizzo
Summary: This study compared the cost-utility of robot-assisted radical cystectomy (RARC) and open radical cystectomy (ORC) for bladder cancer patients. The results did not provide a definitive recommendation for RARC, as the incremental cost-effectiveness ratio (ICER) did not fall below the threshold. Further research is needed to justify the intervention and determine its cost-effectiveness.
Article
Oncology
Giorgio Bogani, Violante Di Donato, Andrea Papadia, Alessandro Buda, Jvan Casarin, Francesco Multinu, Francesco Plotti, Ilaria Cuccu, Tullio Golia D'Auge, Maria Luisa Gasparri, Ciro Pinelli, Anna Myriam Perrone, Fabio Barra, Flavia Sorbi, Antonella Cromi, Giampaolo Di Martino, Innocenza Palaia, Giorgia Perniola, Simone Ferrero, Pierandrea De Iaco, Chiara Perrone, Roberto Angioli, Daniela Luvero, Ludovico Muzii, Fabio Ghezzi, Fabio Landoni, Michael D. Mueller, Pierluigi Benedetti Panici, Francesco Raspagliesi
Summary: This study evaluated the long-term survival of three different approaches of nodal assessment in endometrial cancer patients and found that sentinel lymph node mapping (SNM) provides similar long-term oncologic outcomes to lymphadenectomy (LND).
GYNECOLOGIC ONCOLOGY
(2022)
Article
Oncology
Sarah Bell, Taylor Orellana, Alison Garrett, Kenneth Smith, Haeyon Kim, Abigail Rosiello, Shannon Rush, Jessica Berger, Jamie Lesnock
Summary: In this study, a cost-effectiveness analysis was conducted to assess the use of extended prophylactic anticoagulation after minimally invasive staging surgery for endometrial cancer. The results showed that no extended pharmacologic anticoagulation was superior to extended prophylactic enoxaparin and apixaban in clinically early-stage endometrial cancer patients undergoing minimally invasive surgery. Prophylactic apixaban for 7 days post-operatively is recommended for select patients when the risk of DVT is 4.8% or higher.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
(2023)
Article
Surgery
Xiaodong Chen, Michael Meara, Alan Harzman, Heidi Pieper, E. Christopher Ellison
Summary: The involvement of senior residents in noncomplex robotic surgeries does not significantly prolong the surgery duration or increase the cost. This suggests that training in noncomplex robotic surgeries can be efficiently incorporated into the residency curriculum.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2023)
Article
Oncology
Giacomo Corrado, Enrico Vizza, Anna Myriam Perrone, Liliana Mereu, Vito Cela, Francesco Legge, Georgios Hilaris, Tina Pasciuto, Marco D'Indinosante, Eleonora La Fera, Camilla Certelli, Valentina Bruno, Stylianos Kogeorgos, Francesco Fanfani, Pierandrea De Iaco, Giovanni Scambia, Valerio Gallotta
Summary: This study evaluated the peri-operative and oncological outcomes of elderly endometrial cancer patients who underwent laparoscopic or robotic surgery, finding no significant differences in surgical and survival outcomes between the two groups. However, robotic surgery showed lower blood losses and longer operative times compared to laparoscopic surgery. Ultimately, neither approach demonstrated superiority in terms of survival outcomes, highlighting the need for individual evaluation to determine the best surgical approach.
FRONTIERS IN ONCOLOGY
(2021)
Article
Surgery
Ayesha P. Ng, Yas Sanaiha, Syed Shahyan Bakhtiyar, Shayan Ebrahimian, Corynn Branche, Peyman Benharash
Summary: This study compared the hospitalization costs and clinical outcomes between robotic-assisted surgery and laparoscopic approaches for major abdominal operations, and found that the costs of robotic-assisted surgery were higher but did not result in significant clinical benefits.
Article
Oncology
T. J. Orellana, H. Kim, S. Beriwal, R. Bhargava, J. Berger, R. J. Buckanovich, L. G. Coffman, M. Courtney-Brooks, H. Mahdi, A. B. Olawaiye, P. Sukumvanich, S. E. Taylor, K. J. Smith, J. L. Lesnock
Summary: The study evaluates the cost-effectiveness of tumor molecular classification in early-stage high-risk endometrial cancer patients, demonstrating that it is a cost-effective approach with robust results.
GYNECOLOGIC ONCOLOGY
(2022)
Article
Oncology
Dimitrios Nasioudis, Stefan Gysler, Nawar Latif, Lory Cory, Robert L. Giuntoli II, Sarah H. Kim, Fiona Simpkins, Lainie Martin, Emily M. Ko
Summary: The prevalence of ERBB2 gene amplification was investigated among patients with gynecologic malignancies. The study found that ERBB2 amplification is frequently encountered in uterine serous carcinoma and mucinous ovarian carcinoma, but less common in endometrioid endometrial carcinoma.
GYNECOLOGIC ONCOLOGY
(2024)